CRNX Crinetics Pharmaceuticals Inc

$42.67

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/17/2025

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.

Website: https://www.crinetics.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1658247
Address
10222 BARNES CANYON ROAD, BLDG. #2, SAN DIEGO, CA, US
Valuation
Market Cap
$2.83B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
2.14
Performance
EPS
$-3.69
Dividend Yield
—
Profit Margin
0.00%
ROE
-32.00%
Technicals
50D MA
$33.29
200D MA
$47.24
52W High
$62.53
52W Low
$24.10
Fundamentals
Shares Outstanding
93M
Target Price
$75.36
Beta
0.38

CRNX EPS Estimates vs Actual

● Estimated
● Actual

CRNX News & Sentiment

Nov 10, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
SAN DIEGO, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Crinetics Pharmaceuticals, Inc. ( Nasdaq: CRNX ) today announced that on November 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 37,675 shares of its common stock ...
Nov 07, 2025 • Motley Fool SOMEWHAT-BULLISH
Why Crinetics Pharmaceuticals Stock Was Sliding on Friday
The company is preparing a rollout of its recently FDA-approved acromegaly treatment.
Nov 06, 2025 • Zacks Commentary NEUTRAL
Crinetics Pharmaceuticals, Inc. ( CRNX ) Reports Q3 Loss, Lags Revenue Estimates
CRINETICS PHARM (CRNX) delivered earnings and revenue surprises of -8.66% and -94.70%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 13, 2025 • Benzinga SOMEWHAT-BEARISH
Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Advantage Solutions ( NASDAQ:ADV ) , Strive ( NASDAQ:ASST )
U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Monday. Shares of Fastenal Company ( NASDAQ:FAST ) fell sharply in pre-market trading following downbeat third-quarter earnings.
Oct 10, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
SAN DIEGO, Oct. 10, 2025 ( GLOBE NEWSWIRE ) -- Crinetics Pharmaceuticals, Inc. ( Nasdaq: CRNX ) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 78,975 shares of its common stock ...
Sep 28, 2025 • Motley Fool SOMEWHAT-BULLISH
Is Crinetics Pharmaceuticals Stock a Buy?
The FDA just handed this clinical-stage biotech its golden ticket -- but at a $4.3 billion valuation, the market's already pricing in a fair amount of commercial success.
Sentiment Snapshot

Average Sentiment Score:

0.158
50 articles with scored sentiment

Overall Sentiment:

Bullish

CRNX Reported Earnings

Aug 07, 2025
Jun 30, 2025 (Pre market)
-0.13 Surprise
  • Reported EPS: $-1.23
  • Estimate: $-1.10
  • Whisper: —
  • Surprise %: -11.8%
May 08, 2025
Mar 31, 2025 (Pre market)
-0.09 Surprise
  • Reported EPS: $-1.04
  • Estimate: $-0.95
  • Whisper: —
  • Surprise %: -9.2%
Feb 27, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $-0.88
  • Estimate: $-0.89
  • Whisper: —
  • Surprise %: 1.3%
Nov 12, 2024
Sep 30, 2024 (Post market)
-0.05 Surprise
  • Reported EPS: $-0.96
  • Estimate: $-0.91
  • Whisper: —
  • Surprise %: -5.5%
Aug 08, 2024
Jun 30, 2024 (Post market)
-0.08 Surprise
  • Reported EPS: $-0.94
  • Estimate: $-0.86
  • Whisper: —
  • Surprise %: -9.3%
May 09, 2024
Mar 31, 2024 (Post market)
-0.12 Surprise
  • Reported EPS: $-0.93
  • Estimate: $-0.81
  • Whisper: —
  • Surprise %: -14.8%
Feb 28, 2024
Dec 31, 2023 (Post market)
-0.04 Surprise
  • Reported EPS: $-0.90
  • Estimate: $-0.86
  • Whisper: —
  • Surprise %: -4.7%
Nov 07, 2023
Sep 30, 2023 (Post market)
-0.15 Surprise
  • Reported EPS: $-1.01
  • Estimate: $-0.86
  • Whisper: —
  • Surprise %: -17.4%
Aug 08, 2023
Jun 30, 2023 (Pre market)
-0.08 Surprise
  • Reported EPS: $-0.94
  • Estimate: $-0.86
  • Whisper: —
  • Surprise %: -9.3%

Financials